SOPHiA GENETICS Expands AstraZeneca Partnership to Advance Liquid Biopsy Worldwide

SOPHiA GENETICS Expands AstraZeneca Partnership to Advance Liquid Biopsy Worldwide

New collaboration from AACR 2025 aims to make non-invasive cancer testing more accessible on a global scale.
Pfizer and Nona Biosciences Present Promising ADC Data Targeting MSLN at AACR 2025

Pfizer and Nona Biosciences Present Promising ADC Data Targeting MSLN at AACR 2025

Innovative antibody-drug conjugates mark a new frontier in targeted cancer therapies.
Innovent Showcases Breakthrough Preclinical Data on Novel Antibodies at AACR 2025

Innovent Showcases Breakthrough Preclinical Data on Novel Antibodies at AACR 2025

Cutting-edge bispecific and tri-specific antibody therapies headline Innovent’s research portfolio.
ImmVira Unveils Promising Clinical Data on MVR-C5252 for Malignant Glioma at AACR 2025

ImmVira Unveils Promising Clinical Data on MVR-C5252 for Malignant Glioma at AACR 2025

New targeted delivery technology offers hope for aggressive brain cancer treatment.